share_log

Oppenheimer Maintains Outperform on Prothena Corp, Raises Price Target to $110

Oppenheimer Maintains Outperform on Prothena Corp, Raises Price Target to $110

奥本海默维持Prothena Corp的跑赢大盘,将目标股价提高至110美元
Benzinga Real-time News ·  2022/09/29 10:13

Oppenheimer analyst Jay Olson maintains Prothena Corp (NASDAQ:PRTA) with a Outperform and raises the price target from $100 to $110.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发